04-25-2024, 01:41 PM
I've been following the development of another medication called Tucatinib. It's approved for exploit in mixture with other drugs for Her2-positive metastatic breast cancer, such as brain metastases. It looks to offer hope for patients who previously had restricted treatment choices.